Clinical trial Recruiting at 1 site Observational Ages 18 to 60

Investigating the glymphatic system's role in migraine

Official title: Discovering the Functional Role of the Glymphatic System in the Genesis of the Migraine Attack

Run by IRCCS San Raffaele · NCT05907655 · Data updated 2026-11-12

This study is trying to see how the brain's cleaning system might affect migraine attacks by looking at brain scans and sleep patterns in people with migraines and healthy individuals.

Quick facts

Study typeObservational
Ages18 Years to 60 Years
SexAll
Enrollment50 (estimated)
SponsorIRCCS San Raffaele
Academic / other
Locations1 site (Milan, Milan)
StatusRecruiting
StartedApril 30, 2023
Main results expectedMarch 30, 2027
Study endsApril 4, 2027
Registry record updatedNovember 6, 2026
Trial IDNCT05907655 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 to 60 with a diagnosis of migraine according to ICHD-3 criteria.

Probably not a fit

Patients with overuse of acute headache medications or other primary headache disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study explores how the glymphatic system may contribute to migraine attacks by utilizing non-invasive MRI techniques and a model that induces migraines through nitroglycerin administration. It aims to assess the relationship between glymphatic function during migraine episodes, sleep patterns, and levels of neuropeptides associated with migraines. Participants will include individuals diagnosed with migraines and healthy controls, all aged between 18 and 60 years.

Why it matters

Potential benefit: If successful, this study could enhance understanding of migraine mechanisms and lead to improved treatment strategies.

How similar studies have gone: While the glymphatic system's role in migraines is a relatively novel area of investigation, similar studies have shown promising results in understanding other neurological conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

For patients:

• Diagnosis of migraine, by the ICHD-3 criteria;

For both patients and healthy controls:

* Age between 18 and 60 years;
* Willing and able to comply with scheduled visits.

Exclusion criteria

For patients:

* Overuse of acute medications for headache;
* Continuous or daily headache;
* Other primary headache disorders, with the exception of infrequent tension-type headache.

For healthy controls:

• Any subject with frequent tension type headache, migraine, cluster headache, other pain syndromes or neurological conditions.

For both patients and healthy controls:

* Allergy to nitroglycerin;
* Major psychiatric disorders such as bipolar affective disorder and schizophrenia;
* Cardiovascular diseases that contraindicated the use of nitroglycerin;
* Intracranial hypertension;
* Cerebral haemorrhage;
* Cerebral trauma;
* Pulmonary toxic oedema;
* Closed angle glaucoma;
* Anaemia;
* Pregnancy and breastfeeding;
* Aortic stenosis or significant hypotension (SBP\<90mmHg or \<100mmHg and symptomatic) precluding nitroglycerin administration;
* Use of sildenafil;
* Any person unable to lie still within the environment of the MRI scanner for the required period to perform the study;
* Any person where MRI scanning is contraindicated (metal implants, pacemaker, claustrophobia, etc.);
* Use of illicit drugs;
* MRI head showing any brain pathology, such as space-occupying lesions;
* Any person unable to understand and follow the instructions of the investigators.

Where it's running

  • IRCCS San Raffaele Hospital
    Milan, Milan, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.